Global Herpes Zoster Therapeutics Market 2024-2028
Herpes Zoster Therapeutics Market 2024-2028
The herpes zoster therapeutics market is forecasted to grow by USD 5069.8 mn during 2023-2028, accelerating at a CAGR of 13.7% during the forecast period. The report on the herpes zoster therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increased incidence of herpes zoster, rising geriatric population, and favorable reimbursement policies for medications, including vaccines.
Technavio's herpes zoster therapeutics market is segmented as below:
By Product
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the emerging innovative vaccines for disease management as one of the prime reasons driving the herpes zoster therapeutics market growth during the next few years. Also, vaccination programs and initiatives providing free vaccines and expanding research will lead to sizable demand in the market.
The report on the herpes zoster therapeutics market covers the following areas:
- Herpes Zoster Therapeutics Market sizing
- Herpes Zoster Therapeutics Market forecast
- Herpes Zoster Therapeutics Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading herpes zoster therapeutics market vendors that include Abbott Laboratories, Bausch Health Companies Inc., Cipla Inc., East India Pharmaceutical Works Ltd., East West Pharma India Pvt. Ltd., Eli Lilly and Co., Emcure Pharmaceuticals Ltd., FDC Ltd., GeneOne Life Science Inc., GlaxoSmithKline Plc, Ikon Remedies Pvt. Ltd., Leeford Healthcare Ltd., Maruho Co. Ltd., Merck and Co. Inc., Novartis AG, Sanofi SA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., and Zydus Lifesciences Ltd.. Also, the herpes zoster therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.